RxDoctor Payments Data

Natalie Lyndon

Family · Cincinnati, OHNPI 1598101222

Payments from drug & device makers

$1,014in general payments, 2019–2025

Across 12 payments — averaging $84.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$314
  • AstraZeneca$152
  • Viiv Healthcare Company$124
  • Novo Nordisk$123
  • GSK$121
  • AbbVie$120
  • plus $60 from 2 others

What the payments were for

  • Food & beverage$1,014100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Gilead3$314
AstraZeneca2$152
Viiv Healthcare Company1$124
Novo Nordisk1$123
GSK1$121
AbbVie1$120
Lilly USA, LLC2$35
Dexcom, Inc.1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,014 in reported general payments places this provider in the 70th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$16,262
Medicare patients
134
Services billed
216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate21$342
Rosuvastatin Calcium11$144
Atorvastatin Calcium12$130
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$98
Levothyroxine Sodium16$91
Fluticasone Propionate20$90
Doxycycline Hyclate11$45

Paid to pharmacies, not to this prescriber.

Other family in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →